<bills>
<bill id="5a95101f21e" sscode="CT18">
<number>
<session>2018</session>
  <code>CT</code>
  <type>SB</type>
  <number>246</number>
</number>
<sponsor>
<name><![CDATA[Human Services Committee]]></name>
<URL><![CDATA[]]></URL>
</sponsor>
<title>
<![CDATA[AN ACT LIMITING AUTO REFILLS OF PRESCRIPTION DRUGS COVERED UNDER THE MEDICAID PROGRAM AND REQUIRING THE COMMISSIONER OF SOCIAL SERVICES TO PROVIDE CHIP DATA TO THE HEALTH INFORMATION TECHNOLOGY OFFICER.]]>
</title>
<abstract>
<![CDATA[To prevent unnecessary costs and clinical outcomes associated with prescriptions that are unnecessarily automatically refilled. ]]>
</abstract>
<status>
<statusdt>06/01/2018</statusdt><statusval><![CDATA[Signed by the Governor]]></statusval>
<standardkey>95000</standardkey><standardval>Signed by governor</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5a95101f21e&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5a95101f21e&rtype=status]]>
</statusurl>
<profiles>
<profile id="533b1f0f15bc" status="tracking">
  <pname><![CDATA[ AKW Test|Prior Authorization]]></pname>
<keywords>
  <keyword><![CDATA[drug]]></keyword>
  <keyword><![CDATA[drugs]]></keyword>
  <keyword><![CDATA[health]]></keyword>
  <keyword><![CDATA[insurance]]></keyword>
  <keyword><![CDATA[insurer]]></keyword>
  <keyword><![CDATA[medical]]></keyword>
  <keyword><![CDATA[pharmaceutical]]></keyword>
  <keyword><![CDATA[pharmacy]]></keyword>
  <keyword><![CDATA[prior authorization]]></keyword>
  </keywords>
</profile>
<profile id="5108369623" status="tracking">
  <pname><![CDATA[ Astellas|Company Issues|Pharmacy Benefit Management]]></pname>
<keywords>
  <keyword><![CDATA[benefit]]></keyword>
  <keyword><![CDATA[benefits]]></keyword>
  <keyword><![CDATA[management]]></keyword>
  <keyword><![CDATA[manager]]></keyword>
  <keyword><![CDATA[pharmaceutical]]></keyword>
  <keyword><![CDATA[pharmacy]]></keyword>
  </keywords>
</profile>
<profile id="4f3164841f" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Change in Reimbursement for Medicaid]]></pname>
<keywords>
  <keyword><![CDATA[medicaid]]></keyword>
  <keyword><![CDATA[medical assistance]]></keyword>
  <keyword><![CDATA[pharmacy]]></keyword>
  </keywords>
</profile>
<profile id="4f3164a31f" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Cost-Containment in Medicaid]]></pname>
<keywords>
  <keyword><![CDATA[medicaid]]></keyword>
  <keyword><![CDATA[medical assistance]]></keyword>
  <keyword><![CDATA[reduction]]></keyword>
  </keywords>
</profile>
<profile id="533b1f211631" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Prior Authorization]]></pname>
<keywords>
  <keyword><![CDATA[drug]]></keyword>
  <keyword><![CDATA[drugs]]></keyword>
  <keyword><![CDATA[health]]></keyword>
  <keyword><![CDATA[insurance]]></keyword>
  <keyword><![CDATA[insurer]]></keyword>
  <keyword><![CDATA[medical]]></keyword>
  <keyword><![CDATA[pharmaceutical]]></keyword>
  <keyword><![CDATA[pharmacy]]></keyword>
  <keyword><![CDATA[prior authorization]]></keyword>
  </keywords>
</profile>
<profile id="5739e9cd1b9e" status="tracking">
  <pname><![CDATA[ Xtend|General|Medicaid Billing]]></pname>
<keywords>
  <keyword><![CDATA[bill]]></keyword>
  <keyword><![CDATA[claims]]></keyword>
  <keyword><![CDATA[medicaid]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5b3310251a1" sscode="DC17">
<number>
<session>2017-2018</session>
  <code>DC</code>
  <type>B22</type>
  <number>864</number>
</number>
<sponsor>
<name><![CDATA[City Council Chair Phil Mendelson (DEM-DC)]]></name>
<URL><![CDATA[http://dccouncil.us/council/phil-mendelson]]></URL>
</sponsor>
<title>
<![CDATA[Eviction Reform Emergency Amendment Act of 2018]]>
</title>
<abstract></abstract>
<status>
<statusdt>07/24/2018</statusdt><statusval><![CDATA[Enacted with Act Number A22-0425, Expires on Oct 22, 2018]]></statusval>
<standardkey>99999</standardkey><standardval>Enacted or chaptered</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b3310251a1&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b3310251a1&rtype=status]]>
</statusurl>
<profiles>
<profile id="5537d96f936" status="tracking">
  <pname><![CDATA[ AKW Test|Drug Take Back]]></pname>
<keywords>
  <keyword><![CDATA[medical waste]]></keyword>
  </keywords>
</profile>
<profile id="551455af1ef" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Drug Take Back]]></pname>
<keywords>
  <keyword><![CDATA[medical waste]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5a87ada423da" sscode="IL17">
<number>
<session>2017-2018</session>
  <code>IL</code>
  <type>HB</type>
  <number>5611</number>
</number>
<sponsor>
<name><![CDATA[Rep. Jaime M. Andrade, Jr.]]></name>
<URL><![CDATA[]]></URL>
</sponsor>
<title>
<![CDATA[DEPT-INNOVATION AND TECHNOLOGY]]>
</title>
<abstract>
<![CDATA[Creates the Department of Innovation and Technology Act to codify the changes made in Executive Order 2016-001. Creates the Department of Innovation and Technology. Abolishes the Information Technology Office (also known as the Office of the Chief Information Officer) within the Office of the Governor and transfers its functions, personnel, and property to Department of Innovation and Technology. Provides for the transfer of information technology functions, including related personnel and property, from specified State agencies, boards, and commissions to the Department of Innovation and Technology. Provides for the powers and responsibilities of the Department of Innovation and Technology, including specified programs and initiatives. Provides for the appointment of the Secretary and ... ]]>
</abstract>
<status>
<statusdt>07/20/2018</statusdt><statusval><![CDATA[Public Act . . . . . . . . . 100-0611]]></statusval>
<standardkey>99000</standardkey><standardval>Enacted or chaptered</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5a87ada423da&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5a87ada423da&rtype=status]]>
</statusurl>
<profiles>
<profile id="5728c32c1e2" status="tracking">
  <pname><![CDATA[ Intuit|Cybersecurity|Cyber]]></pname>
<keywords>
  <keyword><![CDATA[communication]]></keyword>
  <keyword><![CDATA[communications]]></keyword>
  <keyword><![CDATA[cybersecurity]]></keyword>
  <keyword><![CDATA[data]]></keyword>
  <keyword><![CDATA[electronic]]></keyword>
  <keyword><![CDATA[privacy]]></keyword>
  </keywords>
</profile>
<profile id="548b173b216" status="tracking">
  <pname><![CDATA[ Navient|Business|Customer Privacy]]></pname>
<keywords>
  <keyword><![CDATA[communication]]></keyword>
  <keyword><![CDATA[communications]]></keyword>
  <keyword><![CDATA[data]]></keyword>
  <keyword><![CDATA[electronic]]></keyword>
  <keyword><![CDATA[personal information]]></keyword>
  <keyword><![CDATA[privacy]]></keyword>
  <keyword><![CDATA[protect]]></keyword>
  <keyword><![CDATA[protection]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="589ec8b1f4" sscode="IL17">
<number>
<session>2017-2018</session>
  <code>IL</code>
  <type>SB</type>
  <number>1936</number>
</number>
<sponsor>
<name><![CDATA[Sen. Pamela Althoff (REP-IL)]]></name>
<URL><![CDATA[http://www.ilga.gov/senate/Senator.asp?GA=100&MemberID=2335]]></URL>
</sponsor>
<title>
<![CDATA[REPEAL FUNDS-PROJECTS-BOARDS]]>
</title>
<abstract>
<![CDATA[Amends the Executive Reorganization Implementation Act. Makes a technical change in a Section concerning the short title. ]]>
</abstract>
<status>
<statusdt>07/20/2018</statusdt><statusval><![CDATA[Public Act . . . . . . . . . 100-0621]]></statusval>
<standardkey>99000</standardkey><standardval>Enacted or chaptered</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=589ec8b1f4&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=589ec8b1f4&rtype=status]]>
</statusurl>
<profiles>
<profile id="544527521fe" status="tracking">
  <pname><![CDATA[ Enhanced|General|Tax Credit]]></pname>
<keywords>
  <keyword><![CDATA[tax credit]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5a87ad31193e" sscode="IL17">
<number>
<session>2017-2018</session>
  <code>IL</code>
  <type>SB</type>
  <number>3452</number>
</number>
<sponsor>
<name><![CDATA[Sen. Terry Link (DEM-IL)]]></name>
<URL><![CDATA[http://www.ilga.gov/senate/Senator.asp?GA=100&MemberID=2311]]></URL>
</sponsor>
<title>
<![CDATA[GAMING-ADVANCE DEPOSIT WAGER]]>
</title>
<abstract>
<![CDATA[Amends the Illinois Horse Racing Act of 1975. Extends the authorization for advance deposit wagering to December 31, 2022 (rather than December 31, 2018). Effective immediately. ]]>
</abstract>
<status>
<statusdt>07/20/2018</statusdt><statusval><![CDATA[Public Act . . . . . . . . . 100-0627]]></statusval>
<standardkey>99000</standardkey><standardval>Enacted or chaptered</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5a87ad31193e&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5a87ad31193e&rtype=status]]>
</statusurl>
<profiles>
<profile id="544527521fe" status="tracking">
  <pname><![CDATA[ Enhanced|General|Tax Credit]]></pname>
<keywords>
  <keyword><![CDATA[tax credit]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="58b14801b0f" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>HB</type>
  <number>137</number>
</number>
<sponsor>
<name><![CDATA[Rep. James Cantwell (DEM-MA)]]></name>
<URL><![CDATA[http://malegislature.gov/Legislators/Profile/JMC2]]></URL>
</sponsor>
<title>
<![CDATA[An Act allowing businesses to sign up for the Do Not Call list]]>
</title>
<abstract>
<![CDATA[Makes technical changes in other parts of GL c.159C to effectuate this redefinition. ]]>
</abstract>
<status>
<statusdt>07/24/2018</statusdt><statusval><![CDATA[House Session HS - 07/25/2018 11:00 AM House Chamber]]></statusval>
<standardkey>45000</standardkey><standardval>Floor vote scheduled (first chamber)</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=58b14801b0f&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=58b14801b0f&rtype=status]]>
</statusurl>
<profiles>
<profile id="548b171b216" status="tracking">
  <pname><![CDATA[ Navient|Business|Telemarketing]]></pname>
<keywords>
  <keyword><![CDATA[telemarketing]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="58b14804129" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>HB</type>
  <number>201</number>
</number>
<sponsor>
<name><![CDATA[Rep. William Straus (DEM-MA)]]></name>
<URL><![CDATA[http://malegislature.gov/Legislators/Profile/WMS1]]></URL>
</sponsor>
<title>
<![CDATA[An Act prohibiting robocalls to all mobile telephone devices]]>
</title>
<abstract>
<![CDATA[Amends provisions of GL c.159C (Telephone Solicitations) to authorize the Attorney General to enforce provisions against robocalls. In particular, the AG may initiate proceedings relating to a knowing violation or threatened knowing violation, and may include an injunction, a civil penalty or $1500-$10,000 for each knowing violation and additional relief in a court of competent jurisdiction. The attorney general may also issue investigative demands and subpoenas, administer oaths and conduct hearings in the course of investigating a violation. A person who has received more than 1 unsolicited telephonic call within a 12-month period by or on behalf of the same person or entity in violation of the prohibition on robocalls may also personally bring an action to enjoin the violation, to ... ]]>
</abstract>
<status>
<statusdt>07/24/2018</statusdt><statusval><![CDATA[House Session HS - 07/25/2018 11:00 AM House Chamber]]></statusval>
<standardkey>45000</standardkey><standardval>Floor vote scheduled (first chamber)</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=58b14804129&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=58b14804129&rtype=status]]>
</statusurl>
<profiles>
<profile id="548b171b216" status="tracking">
  <pname><![CDATA[ Navient|Business|Telemarketing]]></pname>
<keywords>
  <keyword><![CDATA[telemarketing]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="58c108402cb3" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>HB</type>
  <number>1985</number>
</number>
<sponsor>
<name><![CDATA[Rep. Ronald Mariano (DEM-MA)]]></name>
<URL><![CDATA[http://malegislature.gov/Legislators/Profile/R_M1]]></URL>
</sponsor>
<title>
<![CDATA[An Act updating Chapter 93H data security protections to include biometric information]]>
</title>
<abstract>
<![CDATA[Amends GL 93H:1 to provide a definition for biometric indicators and to further provide that the same shall be considered personal information under GL Chapter 93H (Security Breaches). ]]>
</abstract>
<status>
<statusdt>07/24/2018</statusdt><statusval><![CDATA[House Session HS - 07/25/2018 11:00 AM House Chamber]]></statusval>
<standardkey>45000</standardkey><standardval>Floor vote scheduled (first chamber)</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=58c108402cb3&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=58c108402cb3&rtype=status]]>
</statusurl>
<profiles>
<profile id="5728c32c1e2" status="tracking">
  <pname><![CDATA[ Intuit|Cybersecurity|Cyber]]></pname>
<keywords>
  <keyword><![CDATA[data security]]></keyword>
  </keywords>
</profile>
<profile id="548b172e216" status="tracking">
  <pname><![CDATA[ Navient|Business|Breach of Security Notifications]]></pname>
<keywords>
  <keyword><![CDATA[data security]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="58d0cc4a198" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>HB</type>
  <number>2823</number>
</number>
<sponsor>
<name><![CDATA[Rep. John Mahoney (DEM-MA)]]></name>
<URL><![CDATA[http://malegislature.gov/Legislators/Profile/JJM1]]></URL>
</sponsor>
<title>
<![CDATA[An Act to promote economic development and market access for emerging businesses]]>
</title>
<abstract>
<![CDATA[Classifies cereal grains, malted grains, hops, fruits, flowers, plants, vegetables, or pure juices from fruits, vegetables or plants, herbs, other natural flavoring materials or extracts derived from infusions, percolations, or maceration of such materials, as agricultural products under the Buy Massachusetts Program in the Massachusetts Office of Business Development; authorizes emerging breweries to terminate the right to distribute any brands of malt beverages for any licensed wholesaler to whom they have previously made regular sales; defines emerging breweries as those that are privately owned and operated, are managed by the owners and produce less than 30,000 barrels per year; regulates notice to wholesalers of the termination of any distribution; requires emerging brewers to ... ]]>
</abstract>
<status>
<statusdt>07/24/2018</statusdt><statusval><![CDATA[Reported ought NOT to pass by committee (under Joint Rule 10)]]></statusval>
<standardkey>50000</standardkey><standardval>Passed first house</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=58d0cc4a198&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=58d0cc4a198&rtype=status]]>
</statusurl>
<profiles>
<profile id="55de114d1d2" status="tracking">
  <pname><![CDATA[ Heineken|General|Beer Franchise Law]]></pname>
<keywords>
  <keyword><![CDATA[brands]]></keyword>
  <keyword><![CDATA[breweries]]></keyword>
  <keyword><![CDATA[brewers]]></keyword>
  <keyword><![CDATA[brewery]]></keyword>
  </keywords>
</profile>
<profile id="5351ccefd08" status="tracking">
  <pname><![CDATA[ Heineken|General|Franchise law]]></pname>
<keywords>
  <keyword><![CDATA[brands]]></keyword>
  <keyword><![CDATA[breweries]]></keyword>
  <keyword><![CDATA[brewers]]></keyword>
  <keyword><![CDATA[brewery]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5976e92b14ca" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>HB</type>
  <number>3819</number>
</number>
<sponsor>
<name><![CDATA[Governor]]></name>
<URL><![CDATA[]]></URL>
</sponsor>
<title>
<![CDATA[An Act requiring certain electronic toll collection fee notifications by the Massachusetts Department of Transportation]]>
</title>
<abstract>
<![CDATA[...Lane electronic tolling system. The Governor claims that the existing $100 threshold enacted by the legislature would be cost-prohibitive and violate the contract with the 3rd party vendor administering the system. ]]>
</abstract>
<status>
<statusdt>07/24/2018</statusdt><statusval><![CDATA[House Session HS - 07/25/2018 11:00 AM House Chamber]]></statusval>
<standardkey>10000</standardkey><standardval>Assigned to committee (1st chamber)</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5976e92b14ca&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5976e92b14ca&rtype=status]]>
</statusurl>
<profiles>
<profile id="5808ee9910bd" status="tracking">
  <pname><![CDATA[ Navient|Business|Tolls and Vehicle Surcharges]]></pname>
<keywords>
  <keyword><![CDATA[assessed]]></keyword>
  <keyword><![CDATA[toll]]></keyword>
  <keyword><![CDATA[tolling]]></keyword>
  <keyword><![CDATA[tolls]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5976e92c13a" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>HB</type>
  <number>3826</number>
</number>
<sponsor>
<name><![CDATA[Governor]]></name>
<URL><![CDATA[]]></URL>
</sponsor>
<title>
<![CDATA[An Act relative to a report on additional tax reporting requirements]]>
</title>
<abstract>
<![CDATA[Department of Revenue by a year.Section 125 requires the Commissioner of Revenue to report on how he has used the authority granted in the budget to depart from federal requirements for 1099-K reporting (used to report income received from income received from electronic payments such as credit cards, debit cards, PayPal, and other third party payers). Currently, 1099-K reporting is carried out during the first two months of a calendar year, and the affected taxpayers may file the affected returns and pay their taxes as late as October of that calendar year. According to the Governor, a report as of March 15 of that calendar year will not be able to provide meaningful fiscal information. A reporting date of March 15, 2019 will allow for the preparation of a meaningful evaluation of the ... ]]>
</abstract>
<status>
<statusdt>07/24/2018</statusdt><statusval><![CDATA[House Session HS - 07/25/2018 11:00 AM House Chamber]]></statusval>
<standardkey>10000</standardkey><standardval>Assigned to committee (1st chamber)</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5976e92c13a&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5976e92c13a&rtype=status]]>
</statusurl>
<profiles>
<profile id="5a304b2b54" status="tracking">
  <pname><![CDATA[ Intuit|Tax|Financial Services]]></pname>
<keywords>
  <keyword><![CDATA[1099-k]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5a6050f33d" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>HB</type>
  <number>4116</number>
</number>
<sponsor>
<name><![CDATA[Joint Committee on Elder Affairs]]></name>
<URL><![CDATA[]]></URL>
</sponsor>
<title>
<![CDATA[An Act relative to Alzheimer's and related dementias in the Commonwealth]]>
</title>
<abstract>
<![CDATA[Submits various recommendations relating to the treatment of Alzheimer\'s disease in the commonwealth and the administration of Alzheimer\'s related programs; directs the executive office of health and human services to assess all Alzheimer\'s related state programs and to create and maintain an integrated state plan to overcome it; requires the plan to include implementation steps and priorities based on the results of the assessment; establishes and regulates the membership of an advisory council to provide advice to the executive office on Alzheimer\'s, determine the number of people in the Commonwealth with early-onset Alzheimer\'s, determine the needs of such individuals, regardless of age and provide an annual report which evaluates all state funded efforts in research, clinical care ... ]]>
</abstract>
<status>
<statusdt>07/24/2018</statusdt><statusval><![CDATA[House Session HS - 07/25/2018 11:00 AM House Chamber]]></statusval>
<standardkey>70000</standardkey><standardval>Passed second chamber</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5a6050f33d&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5a6050f33d&rtype=status]]>
</statusurl>
<profiles>
<profile id="533b110315c2" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Specialty Tiers]]></pname>
<keywords>
  <keyword><![CDATA[coinsurance]]></keyword>
  <keyword><![CDATA[drug]]></keyword>
  <keyword><![CDATA[health]]></keyword>
  <keyword><![CDATA[medical]]></keyword>
  <keyword><![CDATA[out-of-pocket]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5a868c2830d8" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>HB</type>
  <number>4241</number>
</number>
<sponsor>
<name><![CDATA[House Bills in Third Reading]]></name>
<URL><![CDATA[]]></URL>
</sponsor>
<title>
<![CDATA[An Act removing fees for security freezes and disclosures of consumer credit reports]]>
</title>
<abstract>
<![CDATA[Establishes and modifies various provisions of the General Laws relating to the protection of consumer financial and credit information. In particular, the bill establishes a new GL 93:51B, prohibiting the use of consumer credit reports in connection with credit applications without the written, verbal or electronic consent of the consumer; defines failure to obtain consent as an unfair business practice under GL93A; amends GL 93:56 regarding disclosures made by consumer reporting agencies, by authorizing the delivery of consumer credit reports in electronic format; allows submission of disputes through electronic mail; reduces the timeline for confirmation of receipt of credit freeze requests from 5 days after request to 3 days after receipt; requires consumer reporting agencies to comply ... ]]>
</abstract>
<status>
<statusdt>07/24/2018</statusdt><statusval><![CDATA[Conference committee reported in part - see HB4806]]></statusval>
<standardkey>72000</standardkey><standardval>In conference or conference pending</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5a868c2830d8&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5a868c2830d8&rtype=status]]>
</statusurl>
<profiles>
<profile id="5728c32c1e2" status="tracking">
  <pname><![CDATA[ Intuit|Cybersecurity|Cyber]]></pname>
<keywords>
  <keyword><![CDATA[breach of security]]></keyword>
  <keyword><![CDATA[data breach]]></keyword>
  </keywords>
</profile>
<profile id="548b173b216" status="tracking">
  <pname><![CDATA[ Navient|Business|Customer Privacy]]></pname>
<keywords>
  <keyword><![CDATA[agencies]]></keyword>
  <keyword><![CDATA[agency]]></keyword>
  <keyword><![CDATA[agency's]]></keyword>
  <keyword><![CDATA[credit information]]></keyword>
  <keyword><![CDATA[obtain]]></keyword>
  <keyword><![CDATA[obtainable]]></keyword>
  <keyword><![CDATA[obtained]]></keyword>
  <keyword><![CDATA[obtains]]></keyword>
  <keyword><![CDATA[report]]></keyword>
  <keyword><![CDATA[reporting]]></keyword>
  <keyword><![CDATA[reports]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5aacb9c67ddd" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>HB</type>
  <number>4304</number>
</number>
<sponsor>
<name><![CDATA[Joint Committee on Telecommunications, Utilities &amp; Energy]]></name>
<URL><![CDATA[]]></URL>
</sponsor>
<title>
<![CDATA[An Act relative to hydro]]>
</title>
<abstract>
<![CDATA[Amends GL 25A:11F relating to the renewable energy portfolio standard for retail electricity suppliers; defines relicensed hydroelectric facilities that receive a new license after January 1, 2018 under the Federal Energy Regulatory Commission Rules, as Class I renewable energy generating sources; requires relicensed hydroelectric facilities seeking to operate as a Class I renewable energy generating source to provide formal notice to the department of energy resources. (New draft of HB2697. The new draft replaces the prior text pertaining to net metering tariffs for small hydroelectric power net metering facilities, with new language relating to classification of relicensed hydroelectric facilities as Class I renewable energy generating sources.) ]]>
</abstract>
<status>
<statusdt>07/24/2018</statusdt><statusval><![CDATA[House Session HS - 07/25/2018 11:00 AM House Chamber]]></statusval>
<standardkey>10000</standardkey><standardval>Assigned to committee (1st chamber)</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5aacb9c67ddd&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5aacb9c67ddd&rtype=status]]>
</statusurl>
<profiles>
<profile id="56e71f931f8" status="tracking">
  <pname><![CDATA[ Enhanced|General|Renewable Energy]]></pname>
<keywords>
  <keyword><![CDATA[net metering]]></keyword>
  </keywords>
</profile>
<profile id="52d45d9820d" status="tracking">
  <pname><![CDATA[ Poet|Profile|anti-ethanol and renewable fuel standard]]></pname>
<keywords>
  <keyword><![CDATA[biofuel]]></keyword>
  <keyword><![CDATA[fuel]]></keyword>
  <keyword><![CDATA[fuels]]></keyword>
  <keyword><![CDATA[quality standards]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5b18d47a13b00" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>HB</type>
  <number>4573</number>
</number>
<sponsor>
<name><![CDATA[Governor]]></name>
<URL><![CDATA[]]></URL>
</sponsor>
<title>
<![CDATA[An Act providing for the terms of certain bonds to be issued by the Commonwealth]]>
</title>
<abstract>
<![CDATA[Amends various provisions related to the 2018 Act Financing The Production and Preservation of Housing for Low And Moderate Income Resdients (2018:99); eliminates the January 1, 2018 effective date for both increases in the Massachusetts historic rehabilitation tax credit and the deadline extension to qualify for environmental response actions corporate tax credits; additionally establishes a new effective date of January 1, 2019 for various provisions related to the elimination of eligibility restriction for the low-income housing tax credit, implementation of a new low-income housing tax credit up to $5,000,000 for preserving and improving existing state or federally-assisted housing, and eligibility for and maximum amounts taken under community investment tax credits; limits all bonds ... ]]>
</abstract>
<status>
<statusdt>07/23/2018</statusdt><statusval><![CDATA[Referred to Senate Committee on Ways &amp; Means]]></statusval>
<standardkey>60000</standardkey><standardval>Passed committee in second chamber</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b18d47a13b00&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b18d47a13b00&rtype=status]]>
</statusurl>
<profiles>
<profile id="5363fd942b4" status="tracking">
  <pname><![CDATA[ Enhanced|General|Historic Tax Credit]]></pname>
<keywords>
  <keyword><![CDATA[historic]]></keyword>
  <keyword><![CDATA[rehabilitation]]></keyword>
  <keyword><![CDATA[tax credit]]></keyword>
  <keyword><![CDATA[tax credits]]></keyword>
  </keywords>
</profile>
<profile id="56be19ac359a" status="tracking">
  <pname><![CDATA[ Enhanced|General|LIH Tax Credit]]></pname>
<keywords>
  <keyword><![CDATA[housing tax credit]]></keyword>
  <keyword><![CDATA[low-income housing tax credit]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5b1b77c21c4c" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>HB</type>
  <number>4577</number>
</number>
<sponsor>
<name><![CDATA[Joint Committee on Telecommunications, Utilities &amp; Energy]]></name>
<URL><![CDATA[]]></URL>
</sponsor>
<title>
<![CDATA[An Act relative to net metering]]>
</title>
<abstract>
<![CDATA[New draft of HB 2712. The new draft submits smaller proposed increases in aggregate net metering capacity, and makes technical and grammatical changes to the original text. ]]>
</abstract>
<status>
<statusdt>07/24/2018</statusdt><statusval><![CDATA[House Session HS - 07/25/2018 11:00 AM House Chamber]]></statusval>
<standardkey>10000</standardkey><standardval>Assigned to committee (1st chamber)</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b1b77c21c4c&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b1b77c21c4c&rtype=status]]>
</statusurl>
<profiles>
<profile id="56e71f931f8" status="tracking">
  <pname><![CDATA[ Enhanced|General|Renewable Energy]]></pname>
<keywords>
  <keyword><![CDATA[net metering]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5b1a25fa75b8" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>HB</type>
  <number>4580</number>
</number>
<sponsor>
<name><![CDATA[Rep. Christine Barber (DEM-MA)]]></name>
<URL><![CDATA[http://malegislature.gov/Legislators/Profile/CPB2]]></URL>
</sponsor>
<title>
<![CDATA[An Act authorizing the Somerville Housing Authority to reconstruct the state funded Clarendon Hill public housing project]]>
</title>
<abstract></abstract>
<status>
<statusdt>07/23/2018</statusdt><statusval><![CDATA[Referred to House Committee on Ways &amp; Means]]></statusval>
<standardkey>50000</standardkey><standardval>Passed first house</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b1a25fa75b8&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b1a25fa75b8&rtype=status]]>
</statusurl>
<profiles>
<profile id="56be19ac359a" status="tracking">
  <pname><![CDATA[ Enhanced|General|LIH Tax Credit]]></pname>
<keywords>
  <keyword><![CDATA[housing tax credit]]></keyword>
  <keyword><![CDATA[low-income housing tax credit]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5b46f8fb7c" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>HB</type>
  <number>4732</number>
</number>
<sponsor>
<name><![CDATA[Rep. Jeffrey Sanchez (DEM-MA)]]></name>
<URL><![CDATA[http://malegislature.gov/Legislators/Profile/J_S1]]></URL>
</sponsor>
<title>
<![CDATA[An Act relative to economic development in the commonwealth]]>
</title>
<abstract>
<![CDATA[Massachusetts Growth Capital Corporation. Additional appropriations added during House floor debate include 116,975,000 for municipal public infrastructure grants, and another $8,840,000 for local economic development projects. (Please note that together these two new line-items include almost 120 earmarks as part of the inside language.)\r\rIn the outside sections, among other things, the bill increases the maximum amount of refundable tax credits which may be granted to a project by the EACC from $5,000,000 to $7,500,000; exempts refundable tax credits granted to projects designated as extraordinary economic development opportunities from the maximum credit cap; allows EACC to grant additional credits in excess of existing caps for certified projects designated as extraordinary economic ... ]]>
</abstract>
<status>
<statusdt>07/24/2018</statusdt><statusval><![CDATA[Senate Session SS - 07/25/2018 11:00 AM Gardner Auditorium]]></statusval>
<standardkey>30000</standardkey><standardval>Passed by 1st committee</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b46f8fb7c&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b46f8fb7c&rtype=status]]>
</statusurl>
<profiles>
<profile id="5363fdb122" status="tracking">
  <pname><![CDATA[ Enhanced|General|Capco]]></pname>
<keywords>
  <keyword><![CDATA[small business investment company]]></keyword>
  </keywords>
</profile>
<profile id="5363fd942b4" status="tracking">
  <pname><![CDATA[ Enhanced|General|Historic Tax Credit]]></pname>
<keywords>
  <keyword><![CDATA[historic]]></keyword>
  <keyword><![CDATA[historical]]></keyword>
  <keyword><![CDATA[history]]></keyword>
  <keyword><![CDATA[rehabilitation]]></keyword>
  <keyword><![CDATA[tax credit]]></keyword>
  <keyword><![CDATA[tax credits]]></keyword>
  </keywords>
</profile>
<profile id="565c62bb1d9" status="tracking">
  <pname><![CDATA[ Enhanced|General|Rural Tax Credit]]></pname>
<keywords>
  <keyword><![CDATA[rural]]></keyword>
  <keyword><![CDATA[rural business investment company]]></keyword>
  <keyword><![CDATA[rural growth]]></keyword>
  <keyword><![CDATA[tax credit]]></keyword>
  <keyword><![CDATA[tax credits]]></keyword>
  </keywords>
</profile>
<profile id="544527521fe" status="tracking">
  <pname><![CDATA[ Enhanced|General|Tax Credit]]></pname>
<keywords>
  <keyword><![CDATA[infrastructure]]></keyword>
  <keyword><![CDATA[tax credit]]></keyword>
  </keywords>
</profile>
<profile id="58e53d482e9" status="tracking">
  <pname><![CDATA[ Enhanced|General|Tiger]]></pname>
<keywords>
  <keyword><![CDATA[anniversary of the closing date]]></keyword>
  <keyword><![CDATA[rural business investment company]]></keyword>
  <keyword><![CDATA[rural growth]]></keyword>
  <keyword><![CDATA[small business investment company]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5b4ee1f91d" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>HB</type>
  <number>4742</number>
</number>
<sponsor>
<name><![CDATA[Rep. Jeffrey Sanchez (DEM-MA)]]></name>
<URL><![CDATA[http://malegislature.gov/Legislators/Profile/J_S1]]></URL>
</sponsor>
<title>
<![CDATA[An Act for prevention and access to appropriate care and treatment of addiction]]>
</title>
<abstract>
<![CDATA[...This bill is intended to improve the availability of substance use disorder treatment, by expanding the range of medical professionals authorized to perform the evaluation and by requiring that the emergency department affirmatively connect the patient with the appropriate level of care. The bill also permits medical professionals or police officers to authorize the transport of a patient to a substance use treatment facility for emergency assessment and treatment when the patient presents a risk of serious harm due to addiction and the patient will not agree to voluntary treatment. Additionally, the bill increases access to the overdose drug naloxone by guaranteeing that practitioners who prescribe and pharmacists who dispense naloxone in good faith will be protected from criminal or ... ]]>
</abstract>
<status>
<statusdt>07/24/2018</statusdt><statusval><![CDATA[House Session HS - 07/25/2018 11:00 AM House Chamber]]></statusval>
<standardkey>50000</standardkey><standardval>Passed first house</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b4ee1f91d&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b4ee1f91d&rtype=status]]>
</statusurl>
<profiles>
<profile id="58c03a4f18" status="tracking">
  <pname><![CDATA[ Astellas|Company Issues|Co Pay Cards]]></pname>
<keywords>
  <keyword><![CDATA[cost sharing]]></keyword>
  <keyword><![CDATA[drug]]></keyword>
  <keyword><![CDATA[drugs]]></keyword>
  <keyword><![CDATA[pharmacist]]></keyword>
  <keyword><![CDATA[pharmacist's]]></keyword>
  <keyword><![CDATA[pharmacists]]></keyword>
  <keyword><![CDATA[pharmacological]]></keyword>
  <keyword><![CDATA[pharmacy]]></keyword>
  </keywords>
</profile>
<profile id="4f3164c320" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Electronic Prescribing]]></pname>
<keywords>
  <keyword><![CDATA[electronic prescribing]]></keyword>
  </keywords>
</profile>
<profile id="4f3164eb87" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Prescription Drug Monitoring]]></pname>
<keywords>
  <keyword><![CDATA[drug]]></keyword>
  <keyword><![CDATA[drugs]]></keyword>
  <keyword><![CDATA[monitor]]></keyword>
  <keyword><![CDATA[monitoring]]></keyword>
  <keyword><![CDATA[prescription]]></keyword>
  <keyword><![CDATA[prescriptions]]></keyword>
  </keywords>
</profile>
<profile id="533b110315c2" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Specialty Tiers]]></pname>
<keywords>
  <keyword><![CDATA[cost sharing]]></keyword>
  <keyword><![CDATA[drug]]></keyword>
  <keyword><![CDATA[drugs]]></keyword>
  <keyword><![CDATA[health]]></keyword>
  <keyword><![CDATA[medical]]></keyword>
  <keyword><![CDATA[medicine]]></keyword>
  <keyword><![CDATA[pharmacist]]></keyword>
  <keyword><![CDATA[pharmacist's]]></keyword>
  <keyword><![CDATA[pharmacists]]></keyword>
  <keyword><![CDATA[pharmacological]]></keyword>
  <keyword><![CDATA[pharmacy]]></keyword>
  </keywords>
</profile>
<profile id="570bc93323b" status="tracking">
  <pname><![CDATA[ Mylan|Drug Issues|Oral Contraceptives]]></pname>
<keywords>
  <keyword><![CDATA[pharmacist]]></keyword>
  <keyword><![CDATA[pharmacist's]]></keyword>
  <keyword><![CDATA[pharmacists]]></keyword>
  <keyword><![CDATA[prescribe]]></keyword>
  <keyword><![CDATA[prescribed]]></keyword>
  <keyword><![CDATA[prescribes]]></keyword>
  <keyword><![CDATA[prescribing]]></keyword>
  </keywords>
</profile>
<profile id="546663c8411" status="tracking">
  <pname><![CDATA[ Mylan|Drug Issues|Pharmacists as Healthcare Providers]]></pname>
<keywords>
  <keyword><![CDATA[dispense]]></keyword>
  <keyword><![CDATA[dispensed]]></keyword>
  <keyword><![CDATA[dispenses]]></keyword>
  <keyword><![CDATA[dispensing]]></keyword>
  <keyword><![CDATA[distribute]]></keyword>
  <keyword><![CDATA[furnish]]></keyword>
  <keyword><![CDATA[pharmacist]]></keyword>
  <keyword><![CDATA[pharmacist's]]></keyword>
  <keyword><![CDATA[pharmacists]]></keyword>
  <keyword><![CDATA[prescribe]]></keyword>
  <keyword><![CDATA[prescribed]]></keyword>
  <keyword><![CDATA[prescribes]]></keyword>
  <keyword><![CDATA[prescribing]]></keyword>
  </keywords>
</profile>
<profile id="570bcc501338" status="tracking">
  <pname><![CDATA[ Mylan|General Business Issues|Changes in State Licensing]]></pname>
<keywords>
  <keyword><![CDATA[controlled substance]]></keyword>
  <keyword><![CDATA[controlled substances]]></keyword>
  <keyword><![CDATA[drug]]></keyword>
  <keyword><![CDATA[drugs]]></keyword>
  <keyword><![CDATA[license]]></keyword>
  <keyword><![CDATA[licensed]]></keyword>
  <keyword><![CDATA[licensee]]></keyword>
  <keyword><![CDATA[licenses]]></keyword>
  <keyword><![CDATA[licensing]]></keyword>
  <keyword><![CDATA[licensure]]></keyword>
  <keyword><![CDATA[medical devices]]></keyword>
  <keyword><![CDATA[pharmacist]]></keyword>
  <keyword><![CDATA[pharmacist's]]></keyword>
  <keyword><![CDATA[pharmacists]]></keyword>
  <keyword><![CDATA[pharmacological]]></keyword>
  <keyword><![CDATA[pharmacy]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="58aea5019c" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>SB</type>
  <number>1831</number>
</number>
<sponsor>
<name><![CDATA[Sen. Sonia Chang-Diaz (DEM-MA)]]></name>
<URL><![CDATA[http://malegislature.gov/Legislators/Profile/SCD0]]></URL>
</sponsor>
<title>
<![CDATA[An Act relative to solar power in environmental justice and urban communities]]>
</title>
<abstract>
<![CDATA[Establishes a framework for the allocation of solar energy market net metering credits for low-income and Environmental Justice households; defines low-income households under GL 40T, related to publicly assisted affordable housing; defines environmental justice households as those with an annual median household income equal to or less than 65 percent of the statewide median, or whose population is up to 25 percent minority or lacking English language proficiency; allows low-income and environmental justice households to take the same market net metering credits as municipal or governmental entities; allows low-income solar net metering facilities to receive credits, and exempts them from demand side management and renewable energy kilowatt-hour charges; increases aggregate net metering ... ]]>
</abstract>
<status>
<statusdt>07/24/2018</statusdt><statusval><![CDATA[Senate Session SS - 07/25/2018 11:00 AM Gardner Auditorium]]></statusval>
<standardkey>50000</standardkey><standardval>Passed first house</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=58aea5019c&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=58aea5019c&rtype=status]]>
</statusurl>
<profiles>
<profile id="56e71f931f8" status="tracking">
  <pname><![CDATA[ Enhanced|General|Renewable Energy]]></pname>
<keywords>
  <keyword><![CDATA[net metering]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="58aea501a6" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>SB</type>
  <number>1832</number>
</number>
<sponsor>
<name><![CDATA[Sen. Cynthia Creem (DEM-MA)]]></name>
<URL><![CDATA[http://malegislature.gov/Legislators/Profile/CSC0]]></URL>
</sponsor>
<title>
<![CDATA[An Act to increase container recycling in the Commonwealth]]>
</title>
<abstract>
<![CDATA[Secretary of Environmental Affairs to establish a process for determining the diversion rate and the redemption rate. If, by December 31, 2023, the mean diversion rate for any two year period is found by EOEA to be equal to or greater than the mean redemption rate in the corresponding two year period, then this section is to be repealed automatically. ]]>
</abstract>
<status>
<statusdt>07/24/2018</statusdt><statusval><![CDATA[Senate Session SS - 07/25/2018 11:00 AM Gardner Auditorium]]></statusval>
<standardkey>50000</standardkey><standardval>Passed first house</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=58aea501a6&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=58aea501a6&rtype=status]]>
</statusurl>
<profiles>
<profile id="5351cd0c1833" status="tracking">
  <pname><![CDATA[ Heineken|General|Bottle Bills]]></pname>
<keywords>
  <keyword><![CDATA[beverage containers]]></keyword>
  <keyword><![CDATA[bottle]]></keyword>
  <keyword><![CDATA[container]]></keyword>
  <keyword><![CDATA[containers]]></keyword>
  <keyword><![CDATA[deposit]]></keyword>
  <keyword><![CDATA[deposits]]></keyword>
  <keyword><![CDATA[glass]]></keyword>
  <keyword><![CDATA[recycled]]></keyword>
  <keyword><![CDATA[recycling]]></keyword>
  <keyword><![CDATA[redemption]]></keyword>
  </keywords>
</profile>
<profile id="55dccced1cf" status="tracking">
  <pname><![CDATA[ Heineken|General|Couponing]]></pname>
<keywords>
  <keyword><![CDATA[beer]]></keyword>
  <keyword><![CDATA[redemption]]></keyword>
  </keywords>
</profile>
<profile id="5351cd1c25b" status="tracking">
  <pname><![CDATA[ Heineken|General|Trade Practices and License to Operate]]></pname>
<keywords>
  <keyword><![CDATA[alcoholic beverages]]></keyword>
  <keyword><![CDATA[redemption]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5ae0241556a7" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>SB</type>
  <number>2459</number>
</number>
<sponsor>
<name><![CDATA[Joint Committee on Environment, Natural Resources &amp; Agriculture]]></name>
<URL><![CDATA[]]></URL>
</sponsor>
<title>
<![CDATA[An Act expanding the sale of products by farmer breweries and distilleries]]>
</title>
<abstract>
<![CDATA[Amends GL 138:15F, by permitting municipalities to issue special licenses for the sale of malt beverages produced by farmer-brewers and for the sale of distilled spirits by farmer-distilleries at indoor or outdoor agricultural events; requires the beverages to be sealed and intended for off-premises consumption; limits sample sizes of the malt beverages to 2 ounces; limits sample sizes of distilled spirits to 1/4 of an ounce. (New draft of SB418. The new draft adds the ability to sell sample sizes of distilled spirits, and makes additional grammatical and technical changes to the previous text.) ]]>
</abstract>
<status>
<statusdt>07/24/2018</statusdt><statusval><![CDATA[Senate Session SS - 07/25/2018 11:00 AM Gardner Auditorium]]></statusval>
<standardkey>30000</standardkey><standardval>Passed by 1st committee</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5ae0241556a7&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5ae0241556a7&rtype=status]]>
</statusurl>
<profiles>
<profile id="5351cd1c25b" status="tracking">
  <pname><![CDATA[ Heineken|General|Trade Practices and License to Operate]]></pname>
<keywords>
  <keyword><![CDATA[sample]]></keyword>
  <keyword><![CDATA[samples]]></keyword>
  <keyword><![CDATA[wine]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5b28a68260c6" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>SB</type>
  <number>2563</number>
</number>
<sponsor>
<name><![CDATA[Sen. Michael Moore (DEM-MA)]]></name>
<URL><![CDATA[http://malegislature.gov/Legislators/Profile/MOM0]]></URL>
</sponsor>
<title>
<![CDATA[An Act relative to marijuana-related revenue in the town of Millbury]]>
</title>
<abstract>
<![CDATA[Storm Water Improvements Stabilization Fund. If there is no allocation into the Road Infrastructure Stabilization Fund or an allocation of less than 50%, then the amount otherwise allocable to the Road Infrastructure Stabilization Fund is to be allocated, in equal amounts, to the Other Post-Employment Benefits Stabilization Fund, the Unfunded Retirement Liability Stabilization Fund and the Capital Projects Stabilization Fund. ]]>
</abstract>
<status>
<statusdt>07/24/2018</statusdt><statusval><![CDATA[Senate Session SS - 07/25/2018 11:00 AM Gardner Auditorium]]></statusval>
<standardkey>45000</standardkey><standardval>Floor vote scheduled (first chamber)</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b28a68260c6&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b28a68260c6&rtype=status]]>
</statusurl>
<profiles>
<profile id="5351cd501547" status="tracking">
  <pname><![CDATA[ Heineken|General|Marijuana]]></pname>
<keywords>
  <keyword><![CDATA[marijuana]]></keyword>
  <keyword><![CDATA[tax]]></keyword>
  <keyword><![CDATA[taxes]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5b4ee1fbd6" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>SB</type>
  <number>2610</number>
</number>
<sponsor>
<name><![CDATA[Senate Ways and Means]]></name>
<URL><![CDATA[]]></URL>
</sponsor>
<title>
<![CDATA[An Act promoting net neutrality and consumer protection]]>
</title>
<abstract>
<![CDATA[...New draft of SB 2336. The new language replaces the original proposal banning paid prioritization of internet traffic with business practice disclosures and grades for adherence to net neutrality principles. The changes were made due to concerns with federal pre-emption in this area. ]]>
</abstract>
<status>
<statusdt>07/23/2018</statusdt><statusval><![CDATA[Referred to House Committee on Ways &amp; Means]]></statusval>
<standardkey>55000</standardkey><standardval>Assigned to committee (second chamber)</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b4ee1fbd6&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b4ee1fbd6&rtype=status]]>
</statusurl>
<profiles>
<profile id="5728d40d1de" status="tracking">
  <pname><![CDATA[ Intuit|Data Privacy|Data Privacy]]></pname>
<keywords>
  <keyword><![CDATA[consumer]]></keyword>
  <keyword><![CDATA[consumer's]]></keyword>
  <keyword><![CDATA[financial]]></keyword>
  <keyword><![CDATA[privacy]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5b56caf41d" sscode="MA17">
<number>
<session>2017-2018</session>
  <code>MA</code>
  <type>SB</type>
  <number>2623</number>
</number>
<sponsor>
<name><![CDATA[Senate Bills in Third Reading]]></name>
<URL><![CDATA[]]></URL>
</sponsor>
<title>
<![CDATA[An Act for prevention and access to appropriate care and treatment of addiction]]>
</title>
<abstract></abstract>
<status>
<statusdt>07/23/2018</statusdt><statusval><![CDATA[Printed-as-amended version of SB2609]]></statusval>
<standardkey>10000</standardkey><standardval>Assigned to committee (1st chamber)</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b56caf41d&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b56caf41d&rtype=status]]>
</statusurl>
<profiles>
<profile id="533b1f0f15bc" status="tracking">
  <pname><![CDATA[ AKW Test|Prior Authorization]]></pname>
<keywords>
  <keyword><![CDATA[doctor]]></keyword>
  <keyword><![CDATA[drug]]></keyword>
  <keyword><![CDATA[drugs]]></keyword>
  <keyword><![CDATA[health]]></keyword>
  <keyword><![CDATA[insurance]]></keyword>
  <keyword><![CDATA[insured]]></keyword>
  <keyword><![CDATA[medical]]></keyword>
  <keyword><![CDATA[patient]]></keyword>
  <keyword><![CDATA[patient's]]></keyword>
  <keyword><![CDATA[patients]]></keyword>
  <keyword><![CDATA[pharmaceutical]]></keyword>
  <keyword><![CDATA[pharmacist]]></keyword>
  <keyword><![CDATA[pharmacist's]]></keyword>
  <keyword><![CDATA[pharmacological]]></keyword>
  <keyword><![CDATA[pharmacy]]></keyword>
  <keyword><![CDATA[prior authorization]]></keyword>
  </keywords>
</profile>
<profile id="4f3164631b" status="tracking">
  <pname><![CDATA[ Astellas|Company Issues|Utilization Management]]></pname>
<keywords>
  <keyword><![CDATA[health care]]></keyword>
  <keyword><![CDATA[healthcare]]></keyword>
  <keyword><![CDATA[medical]]></keyword>
  <keyword><![CDATA[utilization review]]></keyword>
  </keywords>
</profile>
<profile id="4f3164a31f" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Cost-Containment in Medicaid]]></pname>
<keywords>
  <keyword><![CDATA[masshealth]]></keyword>
  <keyword><![CDATA[medicaid]]></keyword>
  <keyword><![CDATA[medical assistance]]></keyword>
  <keyword><![CDATA[reduction]]></keyword>
  <keyword><![CDATA[reductions]]></keyword>
  </keywords>
</profile>
<profile id="4f3164c320" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Electronic Prescribing]]></pname>
<keywords>
  <keyword><![CDATA[electronic prescribing]]></keyword>
  </keywords>
</profile>
<profile id="4f3164eb87" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Prescription Drug Monitoring]]></pname>
<keywords>
  <keyword><![CDATA[drug]]></keyword>
  <keyword><![CDATA[drugs]]></keyword>
  <keyword><![CDATA[monitoring]]></keyword>
  <keyword><![CDATA[prescription]]></keyword>
  <keyword><![CDATA[prescriptions]]></keyword>
  </keywords>
</profile>
<profile id="533b1f211631" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Prior Authorization]]></pname>
<keywords>
  <keyword><![CDATA[doctor]]></keyword>
  <keyword><![CDATA[drug]]></keyword>
  <keyword><![CDATA[drugs]]></keyword>
  <keyword><![CDATA[health]]></keyword>
  <keyword><![CDATA[insurance]]></keyword>
  <keyword><![CDATA[insured]]></keyword>
  <keyword><![CDATA[medical]]></keyword>
  <keyword><![CDATA[patient]]></keyword>
  <keyword><![CDATA[patient's]]></keyword>
  <keyword><![CDATA[patients]]></keyword>
  <keyword><![CDATA[pharmaceutical]]></keyword>
  <keyword><![CDATA[pharmacist]]></keyword>
  <keyword><![CDATA[pharmacist's]]></keyword>
  <keyword><![CDATA[pharmacological]]></keyword>
  <keyword><![CDATA[pharmacy]]></keyword>
  <keyword><![CDATA[prior authorization]]></keyword>
  </keywords>
</profile>
<profile id="533b110315c2" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Specialty Tiers]]></pname>
<keywords>
  <keyword><![CDATA[cost sharing]]></keyword>
  <keyword><![CDATA[cost-sharing]]></keyword>
  <keyword><![CDATA[drug]]></keyword>
  <keyword><![CDATA[drugs]]></keyword>
  <keyword><![CDATA[health]]></keyword>
  <keyword><![CDATA[medical]]></keyword>
  <keyword><![CDATA[medicine]]></keyword>
  <keyword><![CDATA[pharmaceutical]]></keyword>
  <keyword><![CDATA[pharmacist]]></keyword>
  <keyword><![CDATA[pharmacist's]]></keyword>
  <keyword><![CDATA[pharmacological]]></keyword>
  <keyword><![CDATA[pharmacy]]></keyword>
  </keywords>
</profile>
<profile id="546663c8411" status="tracking">
  <pname><![CDATA[ Mylan|Drug Issues|Pharmacists as Healthcare Providers]]></pname>
<keywords>
  <keyword><![CDATA[dispense]]></keyword>
  <keyword><![CDATA[dispensed]]></keyword>
  <keyword><![CDATA[dispenses]]></keyword>
  <keyword><![CDATA[dispensing]]></keyword>
  <keyword><![CDATA[distribute]]></keyword>
  <keyword><![CDATA[pharmacist]]></keyword>
  <keyword><![CDATA[pharmacist's]]></keyword>
  <keyword><![CDATA[prescribe]]></keyword>
  <keyword><![CDATA[prescribed]]></keyword>
  <keyword><![CDATA[prescribes]]></keyword>
  <keyword><![CDATA[prescribing]]></keyword>
  </keywords>
</profile>
<profile id="570bcc501338" status="tracking">
  <pname><![CDATA[ Mylan|General Business Issues|Changes in State Licensing]]></pname>
<keywords>
  <keyword><![CDATA[controlled substance]]></keyword>
  <keyword><![CDATA[controlled substances]]></keyword>
  <keyword><![CDATA[drug]]></keyword>
  <keyword><![CDATA[drugs]]></keyword>
  <keyword><![CDATA[license]]></keyword>
  <keyword><![CDATA[licensed]]></keyword>
  <keyword><![CDATA[licensee]]></keyword>
  <keyword><![CDATA[licenses]]></keyword>
  <keyword><![CDATA[licensing]]></keyword>
  <keyword><![CDATA[licensure]]></keyword>
  <keyword><![CDATA[medical devices]]></keyword>
  <keyword><![CDATA[pharmaceutical]]></keyword>
  <keyword><![CDATA[pharmacist]]></keyword>
  <keyword><![CDATA[pharmacist's]]></keyword>
  <keyword><![CDATA[pharmacological]]></keyword>
  <keyword><![CDATA[pharmacy]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="58d48bd2197" sscode="US17">
<number>
<session>2017-2018</session>
  <code>US</code>
  <type>HR</type>
  <number>1676</number>
</number>
<sponsor>
<name><![CDATA[Rep. Eliot Engel (DEM-NY)]]></name>
<URL><![CDATA[http://engel.house.gov]]></URL>
</sponsor>
<title>
<![CDATA[Palliative Care and Hospice Education and Training Act]]>
</title>
<abstract>
<![CDATA[...This bill amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to provide support for Palliative Care and Hospice Education Centers. These centers must improve the training of health professionals in palliative care and establish traineeships for individuals preparing for advanced education nursing degrees, social work degrees, or advanced degrees in physician assistant studies in palliative care.&lt;/p&gt; &lt;p&gt;HHS may provide support to schools of medicine, schools of osteopathic medicine, teaching hospitals, and graduate medical education programs for training physicians who plan to teach palliative medicine.&lt;/p&gt; &lt;p&gt;HHS must: (1) provide Palliative Medicine and Hospice Academic Career Awards to individuals to promote their career development; (2) ... ]]>
</abstract>
<status>
<statusdt>07/24/2018</statusdt><statusval><![CDATA[Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.]]></statusval>
<standardkey>55000</standardkey><standardval>Assigned to committee (second chamber)</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=58d48bd2197&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=58d48bd2197&rtype=status]]>
</statusurl>
<profiles>
<profile id="4f342cd945" status="tracking">
  <pname><![CDATA[ Astellas|Company Issues|Oncology]]></pname>
<keywords>
  <keyword><![CDATA[cancer]]></keyword>
  <keyword><![CDATA[oncology]]></keyword>
  </keywords>
</profile>
<profile id="4f316492bf9" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Comparative Effectiveness]]></pname>
<keywords>
  <keyword><![CDATA[agency for healthcare research and quality]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills>
<relatedbill>
   <url>http://www.cqstatetrack.com/texis/redir?id=58d48bd779</url>
    <type>S</type>
    <number>693</number>
 </relatedbill>
</relatedbills>
<hearings></hearings>
</bill>
<bill id="5ad613afec8" sscode="US17">
<number>
<session>2017-2018</session>
  <code>US</code>
  <type>HR</type>
  <number>5515</number>
</number>
<sponsor>
<name><![CDATA[Rep. Mac Thornberry (REP-TX)]]></name>
<URL><![CDATA[http://thornberry.house.gov]]></URL>
</sponsor>
<title>
<![CDATA[John S. McCain National Defense Authorization Act for Fiscal Year 2019]]>
</title>
<abstract>
<![CDATA[...This bill authorizes FY2019 appropriations and sets forth policies for Department of Defense (DOD) programs and activities, including military personnel strengths. It does not provide budget authority, which is provided in subsequent appropriations legislation. &lt;/p&gt; &lt;p&gt;The bill authorizes appropriations to DOD for: (1) Procurement, including aircraft, missiles, weapons and tracked combat vehicles, ammunition, shipbuilding and conversion, and space procurement; (2) Research, Development, Test, and Evaluation; (3) Operation and Maintenance; (4) Working Capital Funds; (5) Chemical Agents and Munitions Destruction; (6) Drug Interdiction and Counter-Drug Activities; (7) the Defense Inspector General; (8) the Defense Health Program; (9) the Armed Forces Retirement Home; (10) Overseas Contingency ... ]]>
</abstract>
<status>
<statusdt>07/24/2018</statusdt><statusval><![CDATA[Conference papers: Senate report and manager's statement held at the desk in Senate.]]></statusval>
<standardkey>72000</standardkey><standardval>In conference or conference pending</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5ad613afec8&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5ad613afec8&rtype=status]]>
</statusurl>
<profiles>
<profile id="5a313fb88e2" status="tracking">
  <pname><![CDATA[ DJI|General|Drones]]></pname>
<keywords>
  <keyword><![CDATA[aerial]]></keyword>
  <keyword><![CDATA[aircraft]]></keyword>
  <keyword><![CDATA[aircraft']]></keyword>
  <keyword><![CDATA[aircrafts]]></keyword>
  <keyword><![CDATA[drone]]></keyword>
  <keyword><![CDATA[drones]]></keyword>
  <keyword><![CDATA[remotely piloted aircraft]]></keyword>
  <keyword><![CDATA[uas]]></keyword>
  <keyword><![CDATA[uav]]></keyword>
  <keyword><![CDATA[unman]]></keyword>
  <keyword><![CDATA[unmanned]]></keyword>
  <keyword><![CDATA[unmanned aerial]]></keyword>
  <keyword><![CDATA[unmanned aircraft]]></keyword>
  <keyword><![CDATA[unmanned aircraft']]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills>
<relatedbill>
   <url>http://www.cqstatetrack.com/texis/redir?id=5b05349d1ab</url>
    <type>HRES</type>
    <number>905</number>
 </relatedbill>
</relatedbills>
<hearings></hearings>
</bill>
<bill id="5b2b702329e9" sscode="US17">
<number>
<session>2017-2018</session>
  <code>US</code>
  <type>HR</type>
  <number>6147</number>
</number>
<sponsor>
<name><![CDATA[Rep. Ken Calvert (REP-CA)]]></name>
<URL><![CDATA[http://calvert.house.gov]]></URL>
</sponsor>
<title>
<![CDATA[Interior, Environment, Financial Services, and General Government Appropriations Act, 2019]]>
</title>
<abstract>
<![CDATA[&lt;p&gt;&lt;b&gt;Department of the Interior, Environment, and Related Agencies Appropriations Act, 2019&lt;/b&gt;&lt;/p&gt; &lt;p&gt;Provides FY2019 appropriations for the Department of the Interior, the Environmental Protection Agency (EPA), and related agencies. &lt;/p&gt; &lt;p&gt;Provides appropriations to Interior for: &lt;/p&gt; &lt;ul&gt; &lt;li&gt; the Bureau of Land Management, &lt;/li&gt; &lt;li&gt; the U.S. Fish and Wildlife Service, &lt;/li&gt; &lt;li&gt; the National Park Service, &lt;/li&gt; &lt;li&gt; the U.S. Geological Survey, &lt;/li&gt; &lt;li&gt; the Bureau of Ocean Energy Management, &lt;/li&gt; &lt;li&gt; the Bureau of Safety and Environmental Enforcement, &lt;/li&gt; &lt;li&gt; the Office of Surface Mining Reclamation and Enforcement, and &lt;/li&gt; &lt;li&gt; the Bureau of Indian Affairs and Bureau of Indian Education. &lt;/li&gt; &lt;/ul&gt; &lt;p&gt;Provides appropriations to Interior for Departmental Offices, including: ... ]]>
</abstract>
<status>
<statusdt>07/24/2018</statusdt><statusval><![CDATA[Considered by Senate.]]></statusval>
<standardkey>60000</standardkey><standardval>Passed committee in second chamber</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b2b702329e9&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b2b702329e9&rtype=status]]>
</statusurl>
<profiles>
<profile id="58e53d482e9" status="tracking">
  <pname><![CDATA[ Enhanced|General|Tiger]]></pname>
<keywords>
  <keyword><![CDATA[rural job]]></keyword>
  <keyword><![CDATA[small business investment companies]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills>
<relatedbill>
   <url>http://www.cqstatetrack.com/texis/redir?id=5b23871e54f</url>
    <type>S</type>
    <number>3073</number>
 </relatedbill>
</relatedbills>
<hearings></hearings>
</bill>
<bill id="5b58432120" sscode="US17">
<number>
<session>2017-2018</session>
  <code>US</code>
  <type>HR</type>
  <number>6470</number>
</number>
<sponsor>
<name><![CDATA[Rep. Tom Cole (REP-OK)]]></name>
<URL><![CDATA[http://cole.house.gov]]></URL>
</sponsor>
<title>
<![CDATA[Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes.]]>
</title>
<abstract></abstract>
<status>
<statusdt>07/23/2018</statusdt><statusval><![CDATA[Placed on the Union Calendar, Calendar No. 667.]]></statusval>
<standardkey>45000</standardkey><standardval>Floor vote scheduled (first chamber)</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b58432120&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b58432120&rtype=status]]>
</statusurl>
<profiles>
<profile id="54c9175350f" status="tracking">
  <pname><![CDATA[ Astellas|Company Issues|Transparency in Exchanges]]></pname>
<keywords>
  <keyword><![CDATA[exchange]]></keyword>
  <keyword><![CDATA[exchanges]]></keyword>
  <keyword><![CDATA[exchanging]]></keyword>
  <keyword><![CDATA[health care authority]]></keyword>
  <keyword><![CDATA[medicaid]]></keyword>
  <keyword><![CDATA[transparency]]></keyword>
  <keyword><![CDATA[transparent]]></keyword>
  </keywords>
</profile>
<profile id="4f3164841f" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Change in Reimbursement for Medicaid]]></pname>
<keywords>
  <keyword><![CDATA[health care authority]]></keyword>
  <keyword><![CDATA[medicaid]]></keyword>
  <keyword><![CDATA[national average]]></keyword>
  </keywords>
</profile>
<profile id="4f31654e93" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Clinical Trial]]></pname>
<keywords>
  <keyword><![CDATA[clinical trials]]></keyword>
  </keywords>
</profile>
<profile id="4f316492bf9" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Comparative Effectiveness]]></pname>
<keywords>
  <keyword><![CDATA[agency for healthcare research and quality]]></keyword>
  </keywords>
</profile>
<profile id="4f3164d15d8" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Payment Reform]]></pname>
<keywords>
  <keyword><![CDATA[case]]></keyword>
  <keyword><![CDATA[cases]]></keyword>
  <keyword><![CDATA[evidence-based]]></keyword>
  <keyword><![CDATA[price]]></keyword>
  <keyword><![CDATA[rate]]></keyword>
  <keyword><![CDATA[rates]]></keyword>
  </keywords>
</profile>
<profile id="54ede1801ca" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Treatment Pathways]]></pname>
<keywords>
  <keyword><![CDATA[health plan]]></keyword>
  <keyword><![CDATA[incentive payments]]></keyword>
  <keyword><![CDATA[prescribe]]></keyword>
  <keyword><![CDATA[prescribed]]></keyword>
  <keyword><![CDATA[prescription]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills>
<relatedbill>
   <url>http://www.cqstatetrack.com/texis/redir?id=5b3678dd54</url>
    <type>S</type>
    <number>3158</number>
 </relatedbill>
</relatedbills>
<hearings></hearings>
</bill>
<bill id="5b58432157f" sscode="US17">
<number>
<session>2017-2018</session>
  <code>US</code>
  <type>HR</type>
  <number>6478</number>
</number>
<sponsor>
<name><![CDATA[Rep. John Sarbanes (DEM-MD)]]></name>
<URL><![CDATA[http://sarbanes.house.gov]]></URL>
</sponsor>
<title>
<![CDATA[To enhance competition for prescription drugs by increasing the ability of the Department of Justice and Federal Trade Commission to enforce existing antitrust laws regarding biologic and biosimilar products, and for other purposes.]]>
</title>
<abstract></abstract>
<status>
<statusdt>07/23/2018</statusdt><statusval><![CDATA[Referred to the House Committee on Energy and Commerce.]]></statusval>
<standardkey>10000</standardkey><standardval>Assigned to committee (1st chamber)</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b58432157f&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5b58432157f&rtype=status]]>
</statusurl>
<profiles>
<profile id="4f3163fd20" status="tracking">
  <pname><![CDATA[ Astellas|Company Issues|Drug Switching]]></pname>
<keywords>
  <keyword><![CDATA[biosimilar]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
<bill id="5a39fcbe465e" sscode="VT17">
<number>
<session>2017-2018</session>
  <code>VT</code>
  <type>S</type>
  <number>164</number>
</number>
<sponsor>
<name><![CDATA[Sen. Claire Ayer (DEM-VT)]]></name>
<URL><![CDATA[http://legislature.vermont.gov/people/single/2016/14618]]></URL>
</sponsor>
<title>
<![CDATA[An act relating to establishing the Unused Prescription Drug Repository Program]]>
</title>
<abstract>
<![CDATA[An act relating to establishing the Unused Prescription Drug Repository Program ]]>
</abstract>
<status>
<statusdt>05/01/2018</statusdt><statusval><![CDATA[Senate - Signed by Governor on May 1, 2018]]></statusval>
<standardkey>95000</standardkey><standardval>Signed by governor</standardval>
</status>
<billurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5a39fcbe465e&rtype=text]]>
</billurl>
<statusurl>
<![CDATA[http://www.cqstatetrack.com/texis/redir?id=5a39fcbe465e&rtype=status]]>
</statusurl>
<profiles>
<profile id="4f3164841f" status="tracking">
  <pname><![CDATA[ Astellas|Healthcare General|Change in Reimbursement for Medicaid]]></pname>
<keywords>
  <keyword><![CDATA[medicaid]]></keyword>
  <keyword><![CDATA[pharmacies]]></keyword>
  <keyword><![CDATA[pharmacist]]></keyword>
  <keyword><![CDATA[pharmacy]]></keyword>
  </keywords>
</profile>
<profile id="531898e07606" status="tracking">
  <pname><![CDATA[ Intuit|General|Extended Producer Responsibility]]></pname>
<keywords>
  <keyword><![CDATA[ ]]></keyword>
  </keywords>
</profile>
<profile id="546663c8411" status="tracking">
  <pname><![CDATA[ Mylan|Drug Issues|Pharmacists as Healthcare Providers]]></pname>
<keywords>
  <keyword><![CDATA[dispense]]></keyword>
  <keyword><![CDATA[dispensed]]></keyword>
  <keyword><![CDATA[dispensing]]></keyword>
  <keyword><![CDATA[distribute]]></keyword>
  <keyword><![CDATA[distributed]]></keyword>
  <keyword><![CDATA[distributing]]></keyword>
  <keyword><![CDATA[pharmacist]]></keyword>
  <keyword><![CDATA[prescribed]]></keyword>
  <keyword><![CDATA[prescribing]]></keyword>
  </keywords>
</profile>
<profile id="570bcc501338" status="tracking">
  <pname><![CDATA[ Mylan|General Business Issues|Changes in State Licensing]]></pname>
<keywords>
  <keyword><![CDATA[board of pharmacy]]></keyword>
  <keyword><![CDATA[distribute]]></keyword>
  <keyword><![CDATA[distributed]]></keyword>
  <keyword><![CDATA[distributing]]></keyword>
  <keyword><![CDATA[distribution]]></keyword>
  <keyword><![CDATA[distributor]]></keyword>
  <keyword><![CDATA[drug]]></keyword>
  <keyword><![CDATA[drug's]]></keyword>
  <keyword><![CDATA[drugs]]></keyword>
  <keyword><![CDATA[licensed]]></keyword>
  <keyword><![CDATA[pharmacies]]></keyword>
  <keyword><![CDATA[pharmacist]]></keyword>
  <keyword><![CDATA[pharmacy]]></keyword>
  <keyword><![CDATA[wholesale]]></keyword>
  </keywords>
</profile>
</profiles>
<relatedbills></relatedbills>
<hearings></hearings>
</bill>
</bills>
